These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 19814948

  • 1. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH.
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [Abstract] [Full Text] [Related]

  • 2. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D.
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [Abstract] [Full Text] [Related]

  • 3. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA, White KS, Gallagher MW, Woods SW, Shear MK, Gorman JM, Farchione TJ, Barlow DH.
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [Abstract] [Full Text] [Related]

  • 4. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M, Keijsers GP, Hoogduin CA, Hendriks GJ.
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ, Timmerman ME, Mersch PP, van Hout WJ, Visser S, van Dyck R, den Boer JA.
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [Abstract] [Full Text] [Related]

  • 7. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
    Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH.
    J Clin Psychiatry; 2008 Mar; 69(3):400-5. PubMed ID: 18348595
    [Abstract] [Full Text] [Related]

  • 10. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ, van Hout WJ, Mersch PP, Huisman M, Slaap BR, Hale WW, Visser S, van Dyck R, den Boer JA.
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [Abstract] [Full Text] [Related]

  • 11. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
    Van Apeldoorn FJ, Van Hout WJ, Timmerman ME, Mersch PP, den Boer JA.
    J Affect Disord; 2013 Sep 05; 150(2):313-9. PubMed ID: 23676529
    [Abstract] [Full Text] [Related]

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 05; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 13. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.
    J Clin Psychiatry; 2008 Apr 05; 69(4):520-5. PubMed ID: 18278987
    [Abstract] [Full Text] [Related]

  • 14. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.
    Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, Ray S, Money R, Saksa JR, Woods SW, Gorman JM.
    J Clin Psychiatry; 2008 Mar 05; 69(3):418-24. PubMed ID: 18278989
    [Abstract] [Full Text] [Related]

  • 15. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?
    Dougherty DD, Loh R, Jenike MA, Keuthen NJ.
    J Clin Psychiatry; 2006 Jul 05; 67(7):1086-92. PubMed ID: 16889452
    [Abstract] [Full Text] [Related]

  • 16. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.
    J Psychiatr Res; 2002 Jul 05; 36(4):229-36. PubMed ID: 12191627
    [Abstract] [Full Text] [Related]

  • 17. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May 05; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 18. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.
    Arch Gen Psychiatry; 1998 Nov 05; 55(11):1010-6. PubMed ID: 9819070
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
    Liebowitz MR, Asnis G, Mangano R, Tzanis E.
    J Clin Psychiatry; 2009 Apr 05; 70(4):550-61. PubMed ID: 19358784
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM, Kim HM, Powell C, Tuerk PW, Simon NM, Acierno R, Allard CB, Norman SB, Venners MR, Rothbaum BO, Stein MB, Porter K, Martis B, King AP, Liberzon I, Phan KL, Hoge CW.
    JAMA Psychiatry; 2019 Feb 01; 76(2):117-126. PubMed ID: 30516797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.